Throughout the year, we are celebrating not only ASCO’s 50th anniversary, but also the tremendous progress achieved against cancer in the last 50 years. Thanks to the dedication and contributions of patients and researchers, and our nation’s long-standing commitment to funding clinical research, patients have access to more powerful cancer screening, prevention, and treatment options, and are living longer and better lives than ever before.
In fact, ASCO wants your help to identify and recognize the five most pivotal research discoveries that made this progress possible.
Make your voice heard by going to www.CancerProgress.Net and clicking on “Vote: Top Advances.” Here you can cast your ballot for the “Top 5” cancer advances since 1964, the year ASCO was founded. Not only that, you can also tell us why you made your choices.
There are more than 30 landmark research achievements to choose from, all drawn from the Major Milestones section of CancerProgress.Net’s interactive timeline of cancer advances.
This interactive timeline, and CancerProgress.Net as a whole, was developed under the guidance of a 21-member editorial board to provide an easily accessible, visual journey through the history of cancer research and to demonstrate the payoff of sustained U.S. investment in research. The site features news and commentary on cancer research achievements, as well as videos and other multimedia content.
Vote Now—Before It’s Too Late
Vote on your laptop, mobile phone, or tablet device. Then, tweet one or more of your “Top 5” to your colleagues and friends, or share via other social media platforms, such as LinkedIn or Facebook, to encourage others to get involved.
Time is running out to cast a ballot. Voting will close soon after the Annual Meeting, and your vote is important. It will not only help ASCO spread the word about how federal investment in clinical research has paid off for the past 50 years, but it will help us advocate for continued funding that will help sustain the next 50 years of discovery. ■
© 2014. American Society of Clinical Oncology. All rights reserved.